US$ 23.85
safety of glp-1 receptor agonists are increasingly used before pregnancy, but data have been limited., This meta-analysis pooled data from nearly 37,000 pregnancies and found no increased risk major Safety-focused summary of GLP-1 receptor
Description
The upcoming launch of newer, more powerful products could further cement its dominance

Semaglutide and heart failure: updated meta-analysis

Functional studies in rat models have demonstrated that injection of GLP-1 has a dose-dependent effect on reducing feeding behaviors [54, 55], providing evidence of its function as a satiety mediator
This is a crucial finding, as Metabolic Dysfunction-Associated Steatohepatitis (MASH) is a major driver of chronic disease and shortened healthspan

doi: 10.1038/ijo.2013.120